Stool-Based Diagnosis of Helicobacter Pylori, Detection of Virulence Genes and Molecular Analysis of Clarithromycin Resistance in Patients With Gastrointestinal Complaints

Year 2026, Volume: 16 Issue: 1, 29 - 35, 19.03.2026

Elif Aydın , Ayten Nur Uzun Duygu Perçin Renders , Aysun Çalışkan Kartal Süleyman Cosgun

https://izlik.org/JA97AW36TN

Abstract

Aim: This study aimed to detect Helicobacter pylori DNA, major virulence genes (cagA, vacA s1/s2, iceA1/A2), and clarithromycin resistance-associated mutations directly from stool samples of patients presenting with gastrointestinal complaints using molecular techniques. Material and Method: Stool samples from 60 patients collected between April and July 2023 were included in the study. Following DNA extraction, conventional PCR was performed to detect H.pylori and its virulence genes (cagA, vacA s1/s2, iceA1/A2). Real-time PCR (qPCR) was used to identify mutations associated with clarithromycin resistance. Results: H.pylori DNA was detected in 28.3% (n=17) of the samples. Among positive cases, the cagA gene was identified in 17.6% and the vacA s1 subtype in 23.5%. The vacA s2 and iceA1/ A2 genes were not detected. In qPCR analysis, clarithromycinresistance mutations were found in 68.4% of the H.pylori–positive samples (n=19). Conclusion: Molecular stool-based testing appears to be a relevant non-invasive approach for both diagnosis and antibiotic resistance profiling of H.pylori. However, technical limitations such as low DNA yield, PCR inhibitors, and small sample size may have reduced sensitivity. Non-invasive molecular strategies may serve as practical and effective alternatives for treatment stratification, particularly in settings where endoscopic procedures are not readily accessible.

Keywords

Helicobacter pylori , clarithromycin resistance , stool , molecular diagnosis , cagA , vacA

References

• 1. Ailloud F, Didelot X, Woltemate S, Pfaffinger G, Overmann J, Bader RC, et al. Niche-specific adaptation, intragastric migrations and selective sweeps shape within-host evolution of Helicobacter pylori. Nat Commun. 2019;10:2273. https://doi.org/10.1038/s41467-019-10050-1
• 2. Sugano K, Tack J, Kuipers EJ, Graham DY, El-Omar EM, Miura S, et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015;64(9):1353–1367. https://doi.org/10.1136/gutjnl-2015-309252
• 3. McNicholl AG, Bordin DS, Lucendo A, Fadeenko G, Fernandez MC, Voynovan I, et al. Combination of bismuth and standard triple therapy eradicates Helicobacter pylori infection in more than 90% of patients. Clin Gastroenterol Hepatol. 2020;18(1):89–98. https://doi.org/10.1016/j.cgh.2019.03.048
• 4. Sholeh M, Khoshnood S, Azimi T, Mohamadi J, Kaviar VH, Hashemian M, et al. The prevalence of clarithromycin-resistant Helicobacter pylori isolates: a systematic review and meta-analysis. Peer J. 2023;11:e15121. https://doi.org/10.7717/peerj.15121
• 5. Keskin M, Yavuz A. A novel rapid and accurate method for detecting Helicobacter pylori: the modified antigen test. Eur Rev Med Pharmacol Sci. 2022;26(4):1148–1155. https://doi.org/10.26355/eurrev_202202_28106
• 6. Qiu E, Li Z, Han S. Methods for detection of Helicobacter pylori from stool sample: current options and developments. Braz J Microbiol. 2021;52(4):2057–2062. https://doi.org/10.1007/s42770-021-00589-x
• 7. Van den Poel B, Gils S, Micalessi I, Carton S, Christiaens P, Cuyle PJ, et al. Molecular detection of Helicobacter pylori and clarithromycin resistance in gastric biopsies: a prospective evaluation of RIDA® GENE Helicobacter pylori assay. Acta Clinica Belgica. 2021;76(3):177–183. https://doi.org/10.1080/17843286.2019.1685741
• 8. Ren X, Shi Y, Suo B, Yao X, Lu H, Li C, et al. Individualized diagnosis and eradication therapy for Helicobacter pylori infection based on gene detection of clarithromycin resistance in stool specimens: a systematic review and meta‐analysis. Helicobacter. 2023;28(3):e12958. https://doi.org/10.1111/hel.12958
• 9. Graham DY, Moss SF. Antimicrobial susceptibility testing for Helicobacter pylori is now widely available: when, how, why. Am J Gastroenterol. 2022;117(4):524–528. https://doi.org/10.14309/ajg.0000000000001659
• 10. Rimbara E, Fischbach LA, Graham DY. Optimal therapy for Helicobacter pylori infections. Nat Rev Gastroenterol Hepatol. 2011;8(2):79–88. https://doi.org/10.1038/nrgastro.2010.210
• 11. Marrero Rolon R, Cunningham SA, Mandrekar JN, Polo ET, Patel R. Clinical evaluation of a real-time PCR assay for simultaneous detection of Helicobacter pylori and genotypic markers of clarithromycin resistance directly from stool. J Clin Microbiol. 2021;59(5):10–1128. https://doi.org/10.1128/JCM.03040-20
• 12. Beckman E, Saracino I, Fiorini G, Clark C, Slepnev V, Patel D, et al. A novel stool PCR test for Helicobacter pylori may predict clarithromycin resistance and eradication of infection at a high rate. J Clin Microbiol. 2017;55(8):2400–2405. https://doi.org/10.1128/JCM.00506-17
• 13. Kakiuchi T, Okuda M, Matsuo M, Fujimoto K. Smart gene™ as an effective non‐invasive point‐of‐care test to detect Helicobacter pylori clarithromycin‐resistant mutation. J Gastroenterol Hepatol. 2022;37(9):1719–1725. https://doi.org/10.1111/jgh.15887
• 14. Oktem-Okullu S, Cekic-Kipritci Z, Kilic E, Seymen N, Mansur-Ozen N, Sezerman U, et al. Analysis of correlation between the seven important Helicobacter pylori (H.pylori) virulence factors and drug resistance in patients with gastritis. Gastroenterol Res Pract. 2020;2020:3956838. https://doi.org/10.1155/2020/3956838
• 15. Lin TF, Hsu PI. Second-line rescue treatment of Helicobacter pylori infection: where are we now?. World J Gastoentrol. 2018;24(40):4548. https://doi.org/10.3748/wjg.v24.i40.4548
• 16. Thung I, Aramin H, Vavinskaya V, Gupta S, Park JY, Crowe SE, et al. The global emergence of Helicobacter pylori antibiotic resistance. Alimentary pharmacology & therapeutics. 2016;43(4):514–533. https://doi.org/10.1111/apt.13497
• 17. Şen N, Yılmaz Ö, Şimşek İ, Küpelioğlu AA, Ellidokuz, H. Detection of Helicobacter pylori DNA by a simple stool PCR method in adult dyspeptic patients. Helicobacter. 2005;10(4):353–359. https://doi.org/10.1111/j.1523-5378.2005.00326.x
• 18. Smith SI, Fowora MA, Lesi OA, Agbebaku E, Odeigah P, Abdulkareem FB, et al. Application of stool-PCR for the diagnosis of Helicobacter pylori from stool in Nigeria-a pilot study. Springerplus. 2012;1:1–5. https://doi.org/10.1186/2193-1801-1-78
• 19. Fan C-J, Li Z, Zhai L-L, Wang H, Zhao X-L, Xie D-L, et al. Diagnostic accuracy of a real-time PCR assay for detection of Helicobacter pylori and resistance to clarithromycin and levofloxacin directly from stool. Eur Rev Med Pharmacol Sci. 2024;28(12):3836–3840. https://doi.org/10.26355/eurrev_202406_36460
• 20. Moss SF, Dang LP, Chua D, Sobrado J, Zhou Y, Graham, DY. Comparable results of Helicobacter pylori antibiotic resistance testing of stools vs gastric biopsies using next-generation sequencing. Gastroenterology. 2022;162(7):2095–2097. https://doi.org/10.1053/j.gastro.2022.02.027
• 21. Pichon M, Pichard B, Barrioz T, Plouzeau C, Croquet V, Fotsing G, et al. Diagnostic accuracy of a noninvasive test for detection of Helicobacter pylori and resistance to clarithromycin in stool by the Amplidiag H.pylori+ ClariR real-time PCR assay. J Clin Microbiol. 2020;58(4):10–1128. https://doi.org/10.1128/JCM.01787-19
• 22. Ren X, Shi Y, Suo B, Yao X, Lu H, Li C, et al. Individualized diagnosis and eradication therapy for Helicobacter pylori infection based on gene detection of clarithromycin resistance in stool specimens: a systematic review and meta‐analysis. Helicobacter. 2023;28(3):e12958. https://doi.org/10.1111/hel.12958
• 23. Compaore TR, Traore K, Compaore NI, Traore L, Zida S, Soubeiga ST, et al. Helicobacter pylori virulence genes cagA, babA2, and vacA detection in dyspeptic patients from Burkina Faso. Am J Mol Biol. 2023;13(3):141–155. https://doi.org/10.4236/ajmb.2023.133010
• 24. Sicinschi LA, Correa P, Bravo LE, Schneider BG. Detection and typing of Helicobacter pylori cagA/vacA genes by radioactive, one-step polymerase chain reaction in stool samples from children. J Microbiol Methods. 2003;52(2):197–207. https://doi.org/10.1016/S0167-7012(02)00158-6